News
Swiss ministers have met with senior executives of pharmaceutical companies Roche and Novartis to discuss the outlook for the ...
The executive order from President Donald Trump calls on the HHS' Office of the Assistant Secretary for Preparedness and ...
Legend Biotech announced its Q2 earnings, reporting $439m of revenues for its only commercial product, the cell therapy ...
In the final overall survival analysis, researchers pitted Lu-177-PSMA-617 (Pluvicto) against an ARPI in the second-line ...
21h
GlobalData on MSNRemeGen’s telitacicept achieves Phase III win in Sjögren’s syndrome
The drug met its primary endpoints in a Chinese trial, while a Phase III trial in Sjögren's syndrome is currently underway in ...
The state of Maine is being sued by a pharmaceutical company over its discount drug program. Novartis, a New Jersey-based company, is seeking to end Maine’s regulation of the 340B Drug Pricing Program ...
When Helen Nolan met a guy named Shane in a London nightclub in 2003, she never anticipated how her life would change.
When Helen Nolan met a guy named Shane in a London nightclub in 2003, she never anticipated how her life would change.
Swiss ministers met with senior executives from Roche and Novartis to discuss the potential impact of U.S. import tariffs on pharmaceuticals. While pharmaceuticals currently avoid these tariffs, an ...
Novartis, a New Jersey pharmaceutical company, has filed a lawsuit against the state of Maine. Supporters of the law, originally introduced as LD 1018 and enacted as part of the biennial budget in ...
Carvykti's Q1 2025 sales reached $369 million, exceeding consensus estimates by approximately 5% and showing quarter-over-quarter growth of over 10%. This performance has contributed to Legend Biotech ...
Switzerland’s economy unexpectedly grew in the second quarter, maintaining some momentum before the country was hit with one of the highest US tariff rates.The expansion of 0.1% was better than the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results